Literature DB >> 19716513

Recent developments in processing systems for cell and tissue cultures toward therapeutic application.

Masahiro Kino-oka1, Masahito Taya.   

Abstract

Innovative techniques of cell and tissue processing, based on tissue engineering, have been developed for therapeutic applications. Cell expansion and tissue reconstruction through ex vivo cultures are core processes used to produce engineered tissues with sufficient structural integrity and functionality. In manufacturing, strict management against contamination and human error is compelled due to direct use of un-sterilable products and the laboriousness of culture operations, respectively. Therefore, the development of processing systems for cell and tissue cultures is one of the critical issues for ensuring a stable process and quality of therapeutic products. However, the siting criterion of culture systems to date has not been made clear. This review article classifies some of the known processing systems into 'sealed-chamber' and 'sealed-vessel' culture systems based on the difference in their aseptic spaces, and describes the potential advantages of these systems and current states of culture systems, especially those established by Japanese companies. Moreover, on the basis of the guidelines for isolator systems used in aseptic processing for healthcare products, which are issued by the International Organization for Standardization, the siting criterion of the processing systems for cells and tissue cultures is discussed in perspective of manufacturing therapeutic products in consideration of the regulations according to the Good Manufacturing Practice.

Entities:  

Mesh:

Year:  2009        PMID: 19716513     DOI: 10.1016/j.jbiosc.2009.04.007

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  5 in total

1.  A novel, flexible and automated manufacturing facility for cell-based health care products: Tissue Factory.

Authors:  Tetsutaro Kikuchi; Masahiro Kino-Oka; Masanori Wada; Toyoshige Kobayashi; Midori Kato; Shizu Takeda; Hirotsugu Kubo; Tetsuya Ogawa; Hironobu Sunayama; Kazuhito Tanimoto; Manabu Mizutani; Tatsuya Shimizu; Teruo Okano
Journal:  Regen Ther       Date:  2018-09-19       Impact factor: 3.419

2.  Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation.

Authors:  Wen Bao; Ran Liu; Guohua Xia; Fei Wang; Baoan Chen
Journal:  Drug Des Devel Ther       Date:  2019-04-08       Impact factor: 4.162

3.  Approach of resource expenditure estimation toward mechanization in the manufacturing of cell-based products.

Authors:  Manabu Mizutani; Kentaro Nakajima; Masahiro Kino-Oka
Journal:  Regen Ther       Date:  2022-03-10       Impact factor: 3.419

4.  Fabrication of tissue-engineered cell sheets by automated cell culture equipment.

Authors:  Ayako Nishimura; Ryota Nakajima; Ryo Takagi; Guangbin Zhou; Daisuke Suzuki; Masaharu Kiyama; Takayuki Nozaki; Toshiyuki Owaki; Tomomi Takahara; Shigeru Nagai; Taku Nakamura; Masakazu Sugaya; Koichi Terada; Yumiko Igarashi; Hiroko Hanzawa; Teruo Okano; Tatsuya Shimizu; Masayuki Yamato; Shizu Takeda
Journal:  J Tissue Eng Regen Med       Date:  2019-11-14       Impact factor: 3.963

5.  Understanding the formation and behaviors of droplets toward consideration of changeover during cell manufacturing.

Authors:  Yuuki Ogawa; Manabu Mizutani; Ryuta Okamoto; Hideki Kitajima; Sachiko Ezoe; Masahiro Kino-Oka
Journal:  Regen Ther       Date:  2019-04-25       Impact factor: 3.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.